Edwards Lifesciences Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Edwards Lifesciences (EW) Tops Q1 EPS by 18c, Lowers FY Guidance
April 23, 2020 4:18 PM EDTEdwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.51, $0.18 better than the analyst estimate of $1.33. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.08 billion.
GUIDANCE:
Edwards Lifesciences sees FY2020 EPS of $4.75-$5.25, versus the consensus of $5.10. Edwards Lifesciences sees FY2020 revenue of $4-4.5 billion, versus the consensus of $4.37... More
